Adamis Pharmaceuticals Corp·4

Jul 26, 7:06 PM ET

Adamis Pharmaceuticals Corp 4

4 · Adamis Pharmaceuticals Corp · Filed Jul 26, 2013

Insider Transaction Report

Form 4
Period: 2013-07-24
Transactions
  • Sale

    Common Stock, par value $0.0001

    2013-07-24$0.60/sh5,000$3,00029,828,843 total(indirect: See Footnote)
  • Sale

    Common Stock, par value $0.0001

    2013-07-24$0.56/sh32,100$17,97629,796,743 total(indirect: See Footnote)
  • Sale

    Common Stock, par value $0.0001

    2013-07-25$0.56/sh32,900$18,42429,763,843 total(indirect: See Footnote)
  • Sale

    Common Stock, par value $0.0001

    2013-07-26$0.56/sh25,000$14,00029,738,843 total(indirect: See Footnote)
Footnotes (1)
  • [F1]Represents shares of the Issuer's common stock held by Eses Holdings (FZE), a corporation organized under the laws of Sharjah, United Arab Emirates ("Eses"). Ahmed Shayan Fazlur Rahman is the sole shareholder of Eses, and possesses the power to vote and the power to direct the disposition of all securities of the Issuer held by Eses.

Documents

1 file
  • 4
    v351045_form4.xmlPrimary

    OWNERSHIP DOCUMENT